Altay Therapeutics, Inc. SBIR Phase I Award, September 2023
A SBIR Phase I contract was awarded to Altay Therapeutics Inc in September, 2023 for $275,000.0 USD from the National Science Foundation.
Name
# Contributions
Last Contribution
Find more entities like Altay Therapeutics, Inc. SBIR Phase I Award, September 2023
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
